Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Nov 12, 2024
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
SC 13G Nov 8, 2024
SC 13G/A Nov 4, 2024
8-K Nov 4, 2024 8-K
SC 13G Oct 22, 2024
10-Q Aug 12, 2024 10-Q
8-K Aug 12, 2024 8-K
8-K Jul 2, 2024 8-K
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
4 Jul 1, 2024 4
EFFECT May 23, 2024
DEF 14A May 23, 2024 DEF 14A
CORRESP May 21, 2024
UPLOAD May 21, 2024
DEL AM May 14, 2024 DEL AM
S-3 May 13, 2024 S-3
10-Q May 13, 2024 10-Q
← Newer Page 4 of 26 · 641 filings Older →